INVO BioScience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch INVO and buy or sell other stocks, ETFs, and their options commission-free!

About INVO

INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. 

CEO
Steven M. Shum
CEOSteven M. Shum
Employees
42
Employees42
Headquarters
Sarasota, Florida
HeadquartersSarasota, Florida
Founded
Founded
Employees
42
Employees42

INVO Key Statistics

Market cap
1.28M
Market cap1.28M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.68M
Average volume1.68M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$183.60
52 Week high$183.60
52 Week low
$1.38
52 Week low$1.38

Stock Snapshot

With a market cap of 1.28M, INVO BioScience(INVO) trades at $2.68.

INVO BioScience(INVO) stock opened on 2026-06-08 at —. The price climbed to — and dipped to —.

The INVO BioScience(INVO)'s current trading volume is 0, compared to an average daily volume of 1.68M.

During the past year, INVO BioScience(INVO) stock moved between $1.38 at its lowest and $183.60 at its peak.

During the past year, INVO BioScience(INVO) stock moved between $1.38 at its lowest and $183.60 at its peak.

People also own

Based on the portfolios of people who own INVO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.